Pioneering Pharmaceuticals

Making pharmaceuticals more affordable, more available, and better than before

Innovative solutions along the entire pharmaceutical value chain
As part of the TIEFENBACHER GROUP, a 100% family-owned leading health care company, we provide solutions throughout the entire life cycle of a pharmaceutical product. We develop, manufacture, and register innovative as well as generic drugs for our B2B customers. The world´s most trusted brands count on our high excellence in creating best-in-class-dossiers and our ability to manage complex launches in over 80 countries worldwide. Our own laboratories and manufacturing sites empower us to build up efficient supply chains resulting in best value for money for our customers.
There is one purpose driving TIEFENBACHER´s over 600 employees day by day: improving the life of millions of patients worldwide by making pharmaceuticals more affordable, more available, and better than before.

Driving force for advanced medicines

The numbers speak for us

>500million

patients served every year

600+

employees worldwide

180+

dossiers developed/ under development

40+

projects in pipeline

>500million

patients served every year

~600

employees worldwide

100+

dossiers developed

40+

development projects running

>3billion

units inhouse production capacity per year

15.000+

marketing authorizations obtained

80+

different countries where products are being sold

150+

active customers on five continents

~3bn

units production capacity per year

15.000+

marketing authorizations obtained

80+

different countries where products are being sold

150+

active customers on five continents

AET: Specialized in the Development and Commercialization of pharmaceuticals

Our purpose - Care for patients´ health by offering:

Better Affordability

of high-quality medicines

Read more

Better Availability

Throughout the world

Read more

Better Therapy

for patients

Read more

Better Affordability

Advancing Healthcare

Read more

Better Global Availability

Boosting Medicines

Read more

Better Therapy

Creating
Value

Read more

We are TIEFENBACHER GROUP

News

TIEFENBACHER PHARMACEUTICALS announces global launch of Teriflunomide making multiple sclerosis therapy more affordable and better available worldwide

TIEFENBACHER PHARMACEUTICALS, part of TIEFENBACHER GROUP, has successfully developed a global dossier for a generic version of Teriflunomide 7 mg and 14 mg film-coated tablets.    Teriflunomide is an…

Read More

AET Pharma US Inc. Announces Successful approval of generic Posaconazole by the Food and Drug Administration (FDA)

On 1st February 2021, AET Pharma US Inc, part of TIEFENBACHER GROUP, received FDA approval of the Abbreviated New Drug Application (ANDA) for Posaconazole 100 mg Delayed-Release Tablets. This is…

Read More

Global Presence – on five continents

Our path to profitable growth: Creating breakthrough pharmaceuticals

80+

countries

80+

countries

Contact – Partner with us

As the builders of the future, we´re working to improve patients´ lives. By thinking beyond healthcare.




    ALFRED E. TIEFENBACHER (GmbH & Co. KG)
    Van-der-Smissen-Strasse 1
    22767 Hamburg
    Germany

    Phone: +49 40 – 44 18 09 – 0
    Fax: +49 40 – 44 18 09 – 26
    Mail: info@aet.eu